Bex2 controls proliferation of human glioblastoma cells through NF-κB signaling pathway

Area of Science:

• Neuro-oncology
• Molecular biology
• Cellular signaling

Background:

• Glioblastoma is a highly aggressive brain tumor with poor patient outcomes.
• Targeted therapies are needed to improve glioblastoma treatment efficacy.
• The role of Brain expressed X-linked gene 2 (Bex2) in glioma progression requires further elucidation.

Purpose of the Study:

• To investigate the mechanism by which Bex2 promotes glioblastoma cell proliferation.
• To determine the involvement of the NF-κB signaling pathway in Bex2-mediated glioblastoma progression.

Main Methods:

• Glioblastoma cell lines were used to study the effects of Bex2 and NF-κB p65 modulation.
• Quantitative analysis of cell proliferation and protein expression was performed.
• Experiments involving deletion of the nuclear localization signal of Bex2 were conducted.

Main Results:

• Bex2 downregulation inhibited glioblastoma cell proliferation and NF-κB p65 expression.
• Bex2 overexpression enhanced glioblastoma cell proliferation and NF-κB p65 expression.
• The proliferative effect of Bex2 was dependent on NF-κB p65, and Bex2's nuclear localization was crucial for p65 expression.

Conclusions:

• Bex2 promotes human glioblastoma cell proliferation through the NF-κB signaling pathway.
• Bex2's nuclear localization is essential for its role in regulating p65 expression and subsequent cell proliferation.